RAPP - CIK 0002012593
Rapport Therapeutics, Inc. has filed 197 documents with the SEC between 2024 and 2026. The most frequent type is insider trade (71 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Insider trade | 4 | 2025-06-18 | 2025-06-17 |
| Insider trade | 4 | 2025-06-18 | 2025-06-16 |
| Insider trade | 4 | 2025-06-18 | 2025-06-17 |
| Insider sale notice | 144 | 2025-06-16 | - |
| Major company event | 8-K | 2025-06-02 | 2025-06-02 |
| Insider trade | 4 | 2025-05-19 | 2025-05-15 |
| Quarterly report | 10-Q | 2025-05-08 | 2025-03-31 |
| Major company event | 8-K | 2025-05-08 | 2025-05-08 |
| Annual report to shareholders | ARS | 2025-04-24 | 2024-12-31 |
| Proxy materials | DEFA14A | 2025-04-24 | - |
| Proxy statement | DEF 14A | 2025-04-24 | 2025-06-17 |
| Insider trade | 4 | 2025-04-16 | 2025-04-15 |
| Insider trade | 4 | 2025-04-03 | 2025-04-01 |
| Insider trade | 4 | 2025-03-17 | 2025-03-14 |
| Insider sale notice | 144 | 2025-03-14 | - |
| Insider trade | 4 | 2025-03-13 | 2025-03-12 |
| Insider trade | 4 | 2025-03-13 | 2025-03-12 |
| Employee stock plan | S-8 | 2025-03-11 | - |
| Annual report | 10-K | 2025-03-11 | 2024-12-31 |
| Major company event | 8-K | 2025-03-11 | 2025-03-11 |
| Insider trade | 4 | 2025-03-05 | 2025-03-03 |
| New insider ownership | 3 | 2025-03-05 | 2025-03-03 |
| Major company event | 8-K | 2025-03-03 | 2025-03-03 |
| SCHEDULE 13G | - | 2025-02-13 | - |
| Insider trade | 4 | 2025-02-04 | 2025-02-03 |
| Insider trade | 4 | 2025-02-04 | 2025-02-03 |
| Insider trade | 4 | 2025-02-04 | 2025-02-03 |
| Insider trade | 4 | 2025-02-04 | 2025-02-03 |
| Insider trade | 4 | 2025-02-04 | 2025-02-03 |
| Major company event | 8-K | 2025-01-10 | 2025-01-09 |
| Passive ownership stake (update) | SC 13G/A | 2024-11-14 | - |
| Passive ownership stake | SC 13G | 2024-11-14 | - |
| Passive ownership stake | SC 13G | 2024-11-13 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-11-12 | - |
| Insider trade | 4 | 2024-11-07 | 2024-11-07 |
| Insider trade | 4 | 2024-11-07 | 2024-11-07 |
| Insider trade | 4 | 2024-11-07 | 2024-11-07 |
| Insider trade | 4 | 2024-11-07 | 2024-11-07 |
| New insider ownership | 3 | 2024-11-07 | 2024-11-07 |
| New insider ownership | 3 | 2024-11-07 | 2024-11-07 |
| New insider ownership | 3 | 2024-11-07 | 2024-11-07 |
| New insider ownership | 3 | 2024-11-07 | 2024-11-07 |
| Quarterly report | 10-Q | 2024-11-07 | 2024-09-30 |
| Major company event | 8-K | 2024-11-07 | 2024-11-07 |
| Passive ownership stake | SC 13G | 2024-10-18 | - |
| Quarterly report | 10-Q | 2024-08-08 | 2024-06-30 |
| Major company event | 8-K | 2024-08-08 | 2024-08-08 |
| SEC STAFF LETTER | - | 2024-07-26 | - |
| Passive ownership stake | SC 13G | 2024-07-10 | - |
| Insider trade | 4 | 2024-07-03 | 2024-07-01 |